Aptus Pharma Ltd. - Research Center

---

Results

Statement

• P&L

More

Mar ' 25	Mar ' 24	Mar ' 23

Income

Operating income

24.56

17.86

13.90

Expenses

Material consumed

9.49

6.84

4.84

Manufacturing expenses

1.54

2.72

3.19

Personnel expenses

3.57

2.55

1.79

Selling expenses

0.36

0.15

0.11

Adminstrative expenses

4.76

4.05

3.35

Expenses capitalised

-

-

-

Cost of sales

19.71

16.31

13.28

Operating profit

4.85

1.55

0.62

Other recurring income

0.08

0.03

-

Adjusted PBDIT

4.93

1.57

-

Financial expenses

0.47

0.24

0.14

Depreciation

0.27

0.21

0.18

Other write offs

-

-

-

Adjusted PBT

4.20

1.12

0.30

Tax charges

1.10

0.32

0.10

Adjusted PAT

3.10

0.80

0.19

Non recurring items

-

-

-

Other non cash adjustments

-

-

-

Reported net profit

3.10

0.80

0.19

Earnigs before appropriation

4.22

1.12

0.40

Equity dividend

-

-

-

Preference dividend

-

-

-

Dividend tax

-

-

-

Retained earnings

4.22

1.12

0.40